Artificial intelligence is accelerating drug discovery for rare diseases, reducing costs by up to 50% and shortening timelines, enabling bespoke therapies and improving healthcare equity globally. AI ...
Recent FDA-cleared AI systems demonstrate 94-98.5% accuracy in lesion detection, while new federated learning protocols and WHO guidelines address data diversity challenges in global healthcare implem...
